(Q43000009)

English

The cost-effectiveness of introducing nucleic acid testing to test for hepatitis B, hepatitis C, and human immunodeficiency virus among blood donors in Sweden

scientific article published on 16 September 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

The cost-effectiveness of introducing nucleic acid testing to test for hepatitis B, hepatitis C, and human immunodeficiency virus among blood donors in Sweden (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

0 references

author name string

Thomas Davidson

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Bengt Ekermo

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hans Gaines

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Birgitta Lesko

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Britt Åkerlind

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

16 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

421-429

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Assessment of the urgency and deferability of transfusion to inform emergency blood planning and triage: the Bloodhound prospective audit of red blood cell use.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02877.X

21 January 2018

Transfusion-transmitted human immunodeficiency virus infection by a Danish blood donor with a very low viral load in the preseroconversion window phase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02877.X

21 January 2018

Cost-effectiveness of additional hepatitis B virus nucleic acid testing of individual donations or minipools of six donations in the Netherlands

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02877.X

21 January 2018

The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02877.X

21 January 2018

Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02877.X

21 January 2018

Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02877.X

21 January 2018

Detection of HCV and HIV-1 antibody negative infections in Scottish and Northern Ireland blood donations by nucleic acid amplification testing

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02877.X

21 January 2018

Pharmaco-economics of blood transfusion safety: review of the available evidence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02877.X

21 January 2018

Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02877.X

21 January 2018

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02877.X

21 January 2018

Antibody response in primary human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02877.X

21 January 2018

Viral dynamics in primary HIV-1 infection. Karolinska Institutet Primary HIV Infection Study Group.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02877.X

21 January 2018

Economic burden of hepatitis C in Canada and the potential impact of prevention. Results from a disease model.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02877.X

21 January 2018

The cost of care for patients with HIV from the provider economic perspective

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02877.X

21 January 2018

The health-related quality of life in a Swedish sample of HIV-infected persons.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02877.X

21 January 2018

Swedish population health-related quality of life results using the EQ-5D.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02877.X

21 January 2018

EuroQol: the current state of play

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02877.X

21 January 2018

Expensive blood safety initiatives may offer less benefit than we think

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02877.X

21 January 2018

Cost-effectiveness analysis: what it really means for transfusion medicine decision making

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02877.X

21 January 2018

Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02877.X

21 January 2018

Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. The HIV Seroconversion Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02877.X

21 January 2018

Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02877.X

21 January 2018

Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02877.X

21 January 2018

Screening of HIV infection: role of molecular and immunological assays

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02877.X

21 January 2018

A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02877.X

21 January 2018

Diagnosis and procedure-specific survival among transfusion of recipients in 1993 and 2000, Orebro County, Sweden

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02877.X

21 January 2018

Identifiers

10.1111/J.1537-2995.2010.02877.X

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43000009&oldid=1976330904"